Navigation Links
STAAR Surgical Plans Major Presence at ASCRS
Date:4/2/2008

Introduces New Visian ICL(TM) Practice Building Program Launches nanoPOINT(R) Delivery System for Collamer(R) Single Piece IOL

MONROVIA, Calif., April 2, 2008 /PRNewswire/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, plans a major presence at this year's American Society of Cataract and Refractive Surgery, which will be held April 4-9, 2008 in Chicago, Illinois, it was announced here today by Barry Caldwell, President & CEO of STAAR. The Company's plans include sponsoring a certification course for refractive surgeons on the Company's Visian ICL(TM) (Implantable Collamer Lens), the full launch of its nanoPOINT delivery system, demonstrating the new NTIOL designation for the Collamer IOL and the launch of an exciting new marketing program designed to help surgeons build their Visian practice.

"Our plans at ASCRS focus on building our U.S. growth for the Visian ICL, launching our new nanoPOINT delivery system, which can inject the current STAAR Collamer Single Piece intraocular lens (IOL) through a 2.2 mm incision compared to the current requirement of a 2.8 mm to 3.0 mm incision, and capitalizing on the recent NTIOL designation for the Afinity Collamer Aspheric foldable IOL Model CQ2015A. It should be a very active and productive conference for STAAR Surgical," added Mr. Caldwell.

In addition to the certification course on the Visian ICL, STAAR will be introducing a nine- part ICL Growth Program for refractive surgeons. The webinar/conference call program features Dr. Brian Boxer Wachler and focuses on the key elements required to build a successful Visian ICL practice. Dr. Boxer Wachler has developed a very successful Visian ICL practice and was recently featured on the NBC News "Today" show performing bilateral implants of the Visian ICL in his office suite. "In addition to the Today show, the Visian ICL has been featured on numerous shows during the first quarter. Between ABC news in San Francisco, Fox News in Orlando and the Modern Beauty Show on the Style Channel three additional Visian ICL procedures will have aired this month. The ICL Growth Program is designed to help interested surgeons capitalize on the growing consumer awareness of the Visian ICL's benefits and continue our recent progress in the U.S. market. We are so pleased that Dr. Brian Boxer Wachler has agreed to chair this series and share how he has made the Visian ICL a key part of his refractive practice," added Mr. Caldwell.

Many surgeons believe that smaller incisions help reduce surgically induced astigmatism, improve chamber maintenance during the surgical procedure, reduce the risk of infection and reduce healing time for the patient. STAAR Surgical's launch of the micro-incision nanoPOINT delivery system follows a successful pre-release marketing evaluation.

About STAAR Surgical

STAAR is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 40 countries. More information is available at http://www.staar.com.

Safe Harbor

All statements in this press release that are not statements of historical fact are forward-looking statements, including any statements of the plans, strategies, and objectives of management for future operations, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The risks and uncertainties include our limited capital resources and limited access to financing, the challenge of managing foreign subsidiaries, the willingness of surgeons and patients to adopt a new product and procedure and other factors beyond our control, including those detailed from time to time in our reports filed with the Securities and Exchange Commission. STAAR assumes no obligation to update these forward- looking statements to reflect future events or actual outcomes and does not intend to do so.

Contacts: Investors Media

EVC Group EVC Group

Doug Sherk, 415-896-6820 Steve DiMattia, 646-277-8706

Matthew Selinger, 415-896-6817 Chris Gale, 646-201-5431


'/>"/>
SOURCE STAAR Surgical Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. STAAR Surgical Reports Fourth Quarter and Year End Results
2. STAAR Surgicals Visian ICL Procedure Performed Live on NBCs Today show
3. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
4. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
5. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
6. STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference
7. Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical
8. STAAR Surgical Reports Third Quarter Results
9. STAAR Surgical to Purchase Canons Interest in Japanese Joint Venture
10. STAAR Surgical Announces Third Quarter 2007 Earnings Release Date and Conference Call
11. STAAR Surgical Reports Operational Progress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... global clinical supply services, today announced two key appointments and the opening of ... strategic growth plans in the Asia Pacific region. , Howard Kim has joined ...
(Date:5/26/2016)... , ... May 26, 2016 , ... In an effort to provide hair restoration information ... both Snapchat users and those who do not use the app. Dr. Mohebi, the founder ... page, Dr. Mohebi Live . , Dr. Mohebi says, “The positive response to ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... comprehensive treatment for eating disorders, is opening a brand new child and adolescent ... ages 8-17 and their families with even more specialized eating disorder treatment and ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 27, 2016 According to the ... is driving ambulatory blood pressure monitoring system market growth. ... their ability to respond to different pressure rates, leading ... lead to various cardiovascular disorders such as heart failure, ... diseases are growing in prevalence each year. WHO estimates ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharma company focused on the highly lucrative ... a substantial pipeline of potential first-in-class or best-in-class ... are in development with strategic partners. HCM,s profitable ... fast-growing domestic market. We expect progress of the ...
(Date:5/27/2016)... 2016 Kitov Pharmaceuticals ... on late-stage drug development, today announced the completion ... pivotal batches required for registration of KIT-302 with ... follows Kitov,s announcement in December 2015, ... its primary efficacy endpoint. "We are ...
Breaking Medicine Technology: